Ilene Wiggins, RN

CRS:

JHU

Role:

Clinical

Position:

Senior Research Nurse Program Manager for the Johns Hopkins CTU

Email:

iwiggin1@jhmi.edu

As CTU/CRS Coordinator/Research Manager, Ms. Wiggins is responsible for the day-to-day operations of the CTU with respect to domestic (U.S.) research activities. Ms. Wiggins has been a nurse coordinator for the Johns Hopkins AIDS Clinical Trials Unit (ACTU) for more than 20 years, and has been Research Manager/Coordinator for this Unit since 2002. In this role, she works closely with the PI’s, CRS Leaders and investigators to plan and execute the CTU’s scientific activities.

  • Chair, Site Management and Clinical Care Committee (Dec 2016)
  • SMCCC Representative, Protocol Development and implementation Subcommittee of the SMCCC (Dec 2015)
  • SMCCC Representative, Site Operations Subcommittee of the SMCCC (Dec 2016)
  • SMCCC Representative, Training and Education Working Group of the SOS (Dec 2015)
  • Member, Study Coordinators Working Group of the SOS (Jun 2011)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

A5300/P2003: PHOENIx Feasibility Study

Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Read More

A5350: Effects of Visbiome Extra Strength on Gut Microbiome...

Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...

Read More

A5300B/I2003B/PHOENIX, Protecting Households On Exposure to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

Read More